Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €69.02 EUR
Change Today +0.03 / 0.04%
Volume 212.7K
UCB On Other Exchanges
Symbol
Exchange
EN Brussels
OTC US
Frankfurt
As of 11:35 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by UCB SA (UCB) in the last 6 months

Announced 11/7/14
1.53B for Kremers Urban Pharmaceuticals Inc.
Merger/Acquisition

Advent International Corporation and Avista Capital Holdings, L.P. signed an agreement to acquire Kremers Urban Pharmaceuticals Inc. from UCB SA (ENXTBR:UCB) for $1.5 billion in cash on November 7, 2014. The deal financing is provided by Credit Suisse Securities LLC, Morgan Stanley & Co. LLC, Goldman, Sachs & Co and Jefferies LLC. Brian Markison, a healthcare Industry Executive at Avista, will become President and Chief Executive Officer of Kremers Urban. The transaction ...
Read More


UCB's price was unchanged after the transaction was announced on 11/7/14.
Investor / Buyer
Advent International Corporation
Avista Capital Holdings, L.P.
Creditor / Lender
UCB S.A.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UCB:BB €69.02 EUR +0.03

UCB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Endo International PLC $93.27 USD -0.81
Grifols SA €40.43 EUR +0.24
Hospira Inc $87.61 USD -0.05
Lonza Group AG SFr.129.30 CHF +0.20
Sigma-Aldrich Corp $139.00 USD +0.03
View Industry Companies
 

Industry Analysis

UCB

Industry Average

Valuation UCB Industry Range
Price/Earnings 100.0x
Price/Sales 3.5x
Price/Book 2.3x
Price/Cash Flow 56.9x
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UCB SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.